Introduction
The conservative surgical approach is at the core of the concept of 'extreme breast oncoplasty', a combination of oncoplastic techniques aimed at successful breast conservation in selected patients with multifocal or larger than 50-mm tumours [1] . Oncoplastic reconstruction may achieve a cosmetic result superior to a mastectomy with immediate reconstruction [2] . The shorter operative time, associated with reduced postoperative morbidity, allows patients to have a faster recovery after resective surgery, and therefore reduces the risk of possible delay to further oncological treatments. The impact of radiotherapy on breast cosmesis is also more favourable after oncoplastic conservative surgery rather than mastectomy with reconstruction [3] [4] [5] [6] .
Case Report
We present the case of a 52-year-old lady attending our unit with a 7-cm lump in the lateral aspect of the right breast encroaching on the sub-areolar area. Ultrasound and mammogram ( Fig. 1) confirmed the malignant suspicion, and core biopsy of her breast and axilla was subsequently performed. This showed a grade III triple negative invasive ductal carcinoma. The core biopsy in the ipsilateral axillary nodes did not show metastatic disease.
The patient's general condition was good without severe comorbidities. She suffered however from morbid obesity, with a BMI of 41. She had large and ptotic breasts (grade 3, cup FF) (Fig. 2) .
A neoadjuvant chemotherapy approach on the grounds of facilitating breast conservation therapy has been offered. The patient underwent 3 cycles of FEC followed by 3 cycles of docetaxel [7] . Follow-up with MRI scan during the neoadjuvant chemotherapy (as per hospital policy) was not possible because of the patient's habitus. An alternative follow-up with ultrasound has been carried out. The US at the end of the treatment showed some response to the neoadjuvant chemotherapy with maximum tumour diameter of around 5 cm (7 cm at diagnosis).
Given the persistent large size of the mass after primary systemic treatment, a radical surgical approach with mastectomy has been considered and discussed with the patient. The very large ptotic breast, and the overall favourable breast/ tumour volume ratio, has favoured an extreme oncoplastic approach. A wide local excision associated with a wise pattern inferior pedicle breast reduction was performed. Three separate portions of the right breast were removed: tumour wide local excision (Fig. 3 ), lateral and medial parts of the right breast. A unilateral reshaping breast reduction was performed (patient declined contralateral reduction at the time of oncological resection, performed at a later stage). A dual-technique (radioisotope + patent blue dye) sentinel node biopsy was performed at the time of the oncoplastic surgery.
No immediate or postoperative complications occurred. The patient was discharged on the first postoperative day. The total volume of the breast removed accounts for a total weight of 1053 g. Final pathology confirmed a 52-mm grade 3 invasive ductal carcinoma with associated high-grade DCIS with clear excision margins. Pathology of the sentinel node did not show any metastatic disease. At 3-month follow-up, a satisfactory cosmetic result was noted (Fig. 4) . No additional systemic treatment was offered. Adjuvant radiotherapy was delivered 6 weeks after surgery (40 Gy in 15 fractions to the whole breast followed by 8 fraction tumour bed boost). Follow-up with yearly mammogram for 5 years has been offered.
Discussion
Neoadjuvant chemotherapy and extreme oncoplasty is a feasible and safe surgical approach for patients with larger than 5-cm tumour and large breasts. A combined approach accounts for good oncological outcomes and long-term better cosmetic results [8, 9] .
The oncoplastic approach to breast cancer has allowed surgeons to extend the indications for breast-conserving surgery, without compromising neither oncological nor cosmetic outcomes [7, 8, 10] . In the same way that laparoscopy technology has facilitated the development of keyhole surgery [11] , the virtuous combination of breast conservation surgery, oncoplastic techniques and radiotherapy [12] has enabled breast surgeons to take the breast-conserving surgery to a more advanced level. Despite the broader indications to oncoplastic surgery, multifocal tumours and lesions larger than 5 cm have been considered as an indication for a more traditional approach [13, 14] . These cases, defined as extreme cases, are more often deemed as candidate for mastectomy and other forms of reconstruction (autologous flaps, implants).
In our case, we present the breast-conserving approach to a lesion larger than 5 cm, in a patient with ptotic breasts and morbid obesity. Primary systemic treatment has achieved only a b A standard breast-conserving surgery approach would not be appropriate in terms of acceptable cosmetic results. Standard of care would be proceeding with mastectomy +/− immediate breast reconstruction. The extreme oncological resection has been successfully combined with an advanced oncoplastic technique for breast reduction, obtaining a large decrease of the breast volume, and a successful oncological result. The surgical technique has allowed not only to facilitate breastconserving surgery but also to provide an improved bodyimage perception, answering to the specific patient's requests. The oncological resection has not only maintained a normal, functional breast but also offered a superior final aesthetic result.
The decision between mastectomy and breast-conserving surgery should always take into account the likelihood of adjuvant radiotherapy after the resective surgery. In this specific case, the extensive disease at diagnosis and the limited response to the neoadjuvant systemic treatment made very likely the need for radiation therapy even after mastectomy. In this scenario, whole breast reconstruction options should be carefully considered [15] . On the one hand, radiotherapy after implant-based reconstruction has a higher incidence of capsular contracture and implant loss [16] . Equally, a reconstruction with autologous flap could potentially have a higher risk of morbidity and inferior long-term cosmetic results.
The multidisciplinary approach has a pivotal role in any extreme oncoplastic cases [14, 17] . On the one hand, the collaboration with medical oncologists for a neoadjuvant approach can allow downsizing the tumour mass [18] . On the other hand, the translation of sophisticated plastic surgery techniques into oncological resections facilitates, and sometimes enables, a satisfactory extreme oncoplastic approach. In this complex scenario, the breast surgeon has a central invaluable role as the main character of the holistic approach to the treatment of breast cancer. In these extreme cases, the breast surgeon has to act as the coordinator of the therapeutic path, the professional who can take the patient from the cancer diagnosis to a physical and mental status where an improved body-image perception allows a better acceptance of the oncological disease [19] .
Conclusions
Extreme oncoplasty has the potential to extend the inclusion criteria for breast conservation surgery even further. Patient with tumour greater than 5 cm and large ptotic breasts can be successfully treated with a conservative approach, where the oncological resection is finely combined with a b sophisticated plastic techniques. To our knowledge, this is the first published case of extreme oncoplastic surgery where the volume of breast tissue removed surpasses 1000 g, with a very satisfactory cosmetic result. Extreme oncoplastic surgery must be part of a more complex multidisciplinary approach, where the medical approach is integrated into advanced reconstructive surgical techniques. Further randomised controlled trials must be designed in order to confirm the feasibility of oncoplastic surgery in extreme cases of breast tumours.
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